Cayman Islands
# |
Name |
EBITDA |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 9.95 M
|
Dec. 31, 2023 | USD 1.47 | 0.53% |
|
Cayman Islands |
|
2 |
USD -40.87 M
|
Dec. 31, 2023 | USD 8.53 | -0.47% |
|
Cayman Islands |
|
3 |
USD -101.22 M
|
Dec. 31, 2023 | USD 2.01 | 1.52% |
|
Cayman Islands |
The Biotechnology company in Cayman Islands with the highest EBITDA is All Cosmos Bio-Tech Holding Corporation (Taiwan Stock Exchange: 4148.TW) at USD 9.95 M.
The Biotechnology company in Cayman Islands with the lowest EBITDA is Adlai Nortye Ltd. American Depositary Shares (NasdaqGM: ANL) at USD -101.22 M.
The top 10 Biotechnology companies in Cayman Islands by EBITDA are All Cosmos Bio-Tech Holding Corporation, Theravance Biopharma, Inc. and Adlai Nortye Ltd. American Depositary Shares.
The bottom 10 Biotechnology companies in Cayman Islands by EBITDA are Adlai Nortye Ltd. American Depositary Shares, Theravance Biopharma, Inc. and All Cosmos Bio-Tech Holding Corporation.